P585 Impact of timing of thiopurine treatment on first intestinal resection in Crohn’s disease with poor prognostic factors: A nationwide population-based cohort study 2004–2015

Authors:

Abstract
The optimal timing of thiopurine (azathioprine or 6-mercaptopurine) administration is controversial issue in treatment of Crohn's disease (CD) with poor prognostic factors. We performed a nationwide population-based study to investigate the impact of timing of thiopurine treatment on first intestinal resection in CD with poor prognostic factors. Using the National Health Insurance claims data, we collected data on newly diagnosed patients with CD between 2004 and 2015. Among them, patient who have at least two risk factors for progression (diagnosis at age p = 0.225), meanwhile, the risk of surgery was significantly increased in patients started thiopurine at 12–24 months after diagnosis (hazard ratio 1.62, 95% confidence interval 1.10–2.40, p = 0.015). Compared with patients received thiopurine within 6 months, 62% of increase for surgery risk was observed in patients started thiopurine at 12–24 months. Our results suggest that initiation of thiopurine within 1 year after diagnosis may be considered in CD patients with poor prognostic factors.